Management of Fluid Overload with Bumex (Bumetanide) in CVICU Setting

Initial Dosing and Administration

For patients already receiving loop diuretics, the initial IV bumetanide dose should equal or exceed their chronic oral daily dose, administered either as intermittent boluses or continuous infusion, according to the American Heart Association, as published in Circulation 1
Monitor urine output, vital signs, daily weight, and clinical signs of congestion to guide therapy and adjust dosing accordingly, as recommended by the American Heart Association, as published in Circulation 1

Increase the dose of IV bumetanide (up to 2 mg/dose) to enhance diuretic effect, as suggested by the American Heart Association, as published in Circulation 1, 2
Add a second diuretic (e.g., thiazide) to enhance diuretic effect through sequential nephron blockade, as recommended by the American Heart Association, as published in Circulation 1, 2
Consider low-dose dopamine infusion (1-3 mcg/kg/min) as an adjunct to improve renal perfusion and enhance diuresis, as suggested by the American Heart Association, as published in Circulation 1, 2

Measure serum electrolytes, urea nitrogen, and creatinine daily during active diuresis, as recommended by the American College of Cardiology, as published in the Journal of the American College of Cardiology, and the American Heart Association, as published in Circulation 2, 3

For patients with congestive heart failure, assess for signs of fluid overload (increased JVP, pulmonary crackles/rales) and reduce diuretic rate if overdiuresis occurs, as recommended by the Society of Critical Care Medicine, as published in Critical Care 4
In patients with hemodynamic instability, consider temporary reduction or discontinuation of ACE inhibitors, ARBs, and/or aldosterone antagonists until renal function improves, as suggested by the American Heart Association, as published in Circulation 1
For patients with concomitant sepsis, carefully balance fluid resuscitation needs against the risk of pulmonary edema, as recommended by the Society of Critical Care Medicine, as published in Critical Care 5, 6

Consider IV vasodilators (nitroglycerin, nitroprusside) as adjuncts to diuretic therapy for patients with persistent congestion and adequate blood pressure, as recommended by the American Heart Association, as published in Circulation 1
For patients with severe hyponatremia and volume overload, vasopressin antagonists may be considered, as suggested by the American College of Cardiology, as published in the Journal of the American College of Cardiology 3
In cases of refractory congestion despite optimal medical therapy, ultrafiltration may be considered, as recommended by the American Heart Association, as published in Circulation 1, 2